Clinical Trial

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2026 (before its estimated July 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
This open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study. Patients will be divided into two groups; Group A (Injection Etanercept+ Tab methotrexate) and Group B (Injection Etanercept+ Tab methotrexate). Data will be collected at baseline, 1,3 and 6 months. Data will be collected and recorded
Trial Details
NCT Number NCT07386587
Lead Sponsor University of Child Health Sciences and Children's Hospital, Lahore
Conditions Juvenile Idiopathic Arthritis
Enrollment 60 participants
Start Date 2026-01-27
Primary Completion 2026-07-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2026-02-04